Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model

European Journal of Pharmaceutical Sciences

Volumn 75, Issue , 2015, Pages 142-150

  Hafner, Anita ^a   Lovrić, Jasmina ^a   Romić, Marieta Duvnjak ^b   Juretić, Marina ^a   Pepić, Ivan ^a   Cetina Čižmek, Biserka ^b   Filipović Grčić, Jelena ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

Cationic nanosystems; Chitosan; Lecithin; Melatonin; Ocular drug delivery; Pluronic F127

Indexed keywords

CHITOSAN NANOPARTICLE; MELATONIN; POLOXAMER; CHITOSAN; DRUG CARRIER; MICELLE; NANOPARTICLE; PHOSPHATIDYLCHOLINE;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICELLE; MUCOADHESION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; ZETA POTENTIAL; ADHESION; BIOAVAILABILITY; BIOLOGICAL MODEL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; INTRAOCULAR DRUG ADMINISTRATION; PERMEABILITY;

ADHESIVENESS; ADMINISTRATION, OPHTHALMIC; BIOLOGICAL AVAILABILITY; CELL LINE; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; DRUG LIBERATION; HUMANS; LECITHINS; MELATONIN; MICELLES; MODELS, BIOLOGICAL; NANOPARTICLES; PERMEABILITY; POLOXAMER;

EID: 84929711280     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.04.003     Document Type: Article

References (45)

1. A. Agorastos, and C.G. Huber The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential J. Pineal Res. 50 2011 1 7
2. S. Alcantara-Contreras, K. Baba, and G. Tosini Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse Neurosci. Lett. 494 2011 61 64
3. A. Arranja, A.P. Schroder, M. Schmutz, G. Waton, F. Schosseler, and E. Mendes Cytotoxicity and internalization of Pluronic micelles stabilized by core cross-linking J. Control Release 196 2014 87 95
4. E. Basaran, and Y. Yazan Ocular application of chitosan Expert Opin. Drug Deliv. 9 2012 701 712
5. R.S. Bhatta, H. Chandasana, Y.S. Chhonker, C. Rathi, D. Kumar, K. Mitra, and P.K. Shukla Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies Int. J. Pharm. 432 2012 105 112
6. C. Bucolo, S. Salomone, F. Drago, M. Reibaldi, A. Longo, and M.G. Uva Pharmacological management of ocular hypertension: current approaches and future prospective Curr. Opin. Pharmacol. 13 2013 50 55
7. P. Chetoni, L. Panichi, S. Burgalassi, U. Benelli, and M.F. Saettone Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution J. Ocul. Pharmacol. Ther. 16 2000 363 372
8. A.M. de Campos, Y. Diebold, E.L. Carvalho, A. Sanchez, and M.J. Alonso Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity Pharm. Res. 21 2004 803 810
9. M. de la Fuente, B. Seijo, and M.J. Alonso Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy Invest. Ophthalmol. Vis. Sci. 49 2008 2016 2024
10. M. de la Fuente, M. Ravina, P. Paolicelli, A. Sanchez, B. Seijo, and M.J. Alonso Chitosan-based nanostructures: a delivery platform for ocular therapeutics Adv. Drug Deliv. Rev. 62 2010 100 117
11. G. Di Colo, Y. Zambito, S. Burgalassi, I. Nardini, and M.F. Saettone Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin Int. J. Pharm. 273 2004 37 44
12. Y. Diebold, and M. Calonge Applications of nanoparticles in ophthalmology Prog. Retin. Eye Res. 29 2010 596 609
13. Y. Diebold, M. Jarrin, V. Saez, E.L. Carvalho, M. Orea, M. Calonge, B. Seijo, and M.J. Alonso Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP) Biomaterials 28 2007 1553 1564
14. A. Enriquez de Salamanca, Y. Diebold, M. Calonge, C. Garcia-Vazquez, S. Callejo, A. Vila, and M.J. Alonso Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance Invest. Ophthalmol. Vis. Sci. 47 2006 1416 1425
15. O. Felt, P. Furrer, J.M. Mayer, B. Plazonnet, P. Buri, and R. Gurny Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention Int. J. Pharm. 180 1999 185 193
16. M. Garcia-Fuentes, and M.J. Alonso Chitosan-based drug nanocarriers: where do we stand? J. Control Release 161 2012 496 504
17. Y. Gerelli, S. Barbieri, M.T. Di Bari, A. Deriu, L. Cantu, P. Brocca, F. Sonvico, P. Colombo, R. May, and S. Motta Structure of self-organized multilayer nanoparticles for drug delivery Langmuir 24 2008 11378 11384
18. L. Gonzalez-Mariscal, B. Chavez de Ramirez, and M. Cereijido Effect of temperature on the occluding junctions of monolayers of epithelioid cells (MDCK) J. Membr. Biol. 79 1984 175 184
19. A. Hafner, J. Lovric, D. Voinovich, and J. Filipovic-Grcic Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers Int. J. Pharm. 381 2009 205 213
20. A. Hafner, J. Lovric, I. Pepic, and J. Filipovic-Grcic Lecithin/chitosan nanoparticles for transdermal delivery of melatonin J. Microencapsul. 28 2011 807 815
21. M. Hahne, and S. Reichl Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics Int. J. Pharm. 416 2011 268 279
22. J. Jiao Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery Adv. Drug Deliv. Rev. 60 2008 1663 1673
23. S. Kim, Y. Shi, J.Y. Kim, K. Park, and J.X. Cheng Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction Expert Opin. Drug Deliv. 7 2010 49 62
24. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B Biointerfaces 75 2010 1 18
25. J. Liaw, S.F. Chang, and F.C. Hsiao In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles Gene Ther. 8 2001 999 1004
26. A. Martinez-Aguila, B. Fonseca, A. Bergua, and J. Pintor Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions Eur. J. Pharmacol. 701 2013 213 217
27. A. Mediero, P. Alarma-Estrany, and J. Pintor New treatments for ocular hypertension Auton. Neurosci. 147 2009 14 19
28. S. Modi, and B.D. Anderson Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method Mol. Pharm. 10 2013 3076 3089
29. T. Musumeci, C. Bucolo, C. Carbone, R. Pignatello, F. Drago, and G. Puglisi Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits Int. J. Pharm. 440 2013 135 140
30. B. Nagyova, and J.M. Tiffany Components responsible for the surface tension of human tears Curr. Eye Res. 19 1999 4 11
31. I. Pepic, N. Jalsenjak, and I. Jalsenjak Micellar solutions of triblock copolymer surfactants with pilocarpine Int. J. Pharm. 272 2004 57 64
32. I. Pepic, J. Filipovic-Grcic, and I. Jalsenjak Interactions in a nonionic surfactant and chitosan mixtures Colloids Surf. - Physicochem. Eng. Aspects 327 2008 95 102
33. I. Pepic, J. Filipovic-Grcic, and I. Jalsenjak Bulk properties of nonionic surfactant and chitosan mixtures Colloids Surf. - Physicochem. Eng. Aspects 336 2009 135 141
34. I. Pepic, A. Hafner, J. Lovric, B. Pirkic, and J. Filipovic-Grcic A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation J. Pharm. Sci. 99 2010 4317 4325
35. I. Pepic, J. Lovric, and J. Filipovic-Grcic Polymeric micelles in ocular drug delivery: rationale, strategies and challenges Chem. Biochem. Eng. Q. 26 2012 365 377
36. I. Pepic, J. Lovric, and J. Filipovic-Grcic How do polymeric micelles cross epithelial barriers? Eur. J. Pharm. Sci. 50 2013 42 55
37. I. Pepic, J. Lovric, B. Cetina-Cizmek, S. Reichl, and J. Filipović-Grcic Toward the practical implementation of eye-related bioavailability prediction models Drug Discov. Today 19 2014 31 44
38. A.M. Sadeghi, F.A. Dorkoosh, M.R. Avadi, M. Weinhold, A. Bayat, F. Delie, R. Gurny, B. Larijani, M. Rafiee-Tehrani, and H.E. Junginger Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells Eur. J. Pharm. Biopharm. 70 2008 270 278
39. L. Shen, C.R. Weber, and J.R. Turner The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state J. Cell Biol. 181 2008 683 695
40. F. Sonvico, A. Cagnani, A. Rossi, S. Motta, M.T. Di Bari, F. Cavatorta, M.J. Alonso, A. Deriu, and P. Colombo Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction Int. J. Pharm. 324 2006 67 73
41. Y. Tian, and S. Mao Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs Expert Opin. Drug Deliv. 9 2012 687 700
42. Y.C. Tong, S.F. Chang, C.Y. Liu, W.W. Kao, C.H. Huang, and J. Liaw Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters J. Gene Med. 9 2007 956 966
43. V.P. Torchilin Structure and design of polymeric surfactant-based drug delivery systems J. Control Release 73 2001 137 172
44. E. Toropainen, V.P. Ranta, A. Talvitie, P. Suhonen, and A. Urtti Culture model of human corneal epithelium for prediction of ocular drug absorption Invest. Ophthalmol. Vis. Sci. 42 2001 2942 2948
45. Y. Zambito, E. Pedreschi, and G. Di Colo Is dialysis a reliable method for studying drug release from nanoparticulate systems? - A case study Int. J. Pharm. 434 2012 28 34